Central serous chorioretinopathy after nasal corticosteroids in the aviator

Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P. Interventions for central serous chorioretinopathy: a network metaanalysis. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD011841. DOI: 10.1002/14651858.CD011841.pub2.

Evaluation de la Spironolactone dans le traitement des choriorétinites séreuses centrales non résolutives à trois mois. Essai clinique 2016. Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Jin-Liang L, Shu-Lye a. Can Long-Term Corticosteroids Lead to Blindness? A Case Series of Central Serous Chorioretinopathy Induced by Corticosteroids. Ann Acad Med Singapore 2006; 35: 496-9.

Carvalho-Recchia Ca, Yanuzzi La, Negrao S, Spaide Rf, Freund Kb, Rodriguez-Coleman H. Corticosteroids and Central Serous Chorioretinopathy. Ophhalmology 2002; 109: 1834-7.

Bevis T, Ratnakaram R, Smith Mf, Bhatti Mt. Visual Loss Due to Central Serous Chorioretinopathy During Corticosteroid Treatment for Giant Cell Arteritis. Clin Experiment Ophthalmol 2005; 33: 437-9.

Levy J, Marcus M, Belfair N, Klemperer I, Lifshitz T. Central Serous Chorioretinopathy in Patients Receiving Systemic Corticosteroid Therapy. Can J Ophthalmol 2005; 40: 217-21.

Gunjan Prakash, Jain Shephali, Nath Tirupati, Pandey D Ji. Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop Used Nasally for Rhinitis. Middle East Afr J Ophthalmol 2013; 20(4): 363-365.

Haimovici R, Gragoudas Es, Duker Js, Sjaarda Rn, Eliott D. Central Serous Chorioretinopathy Associated with Inhaled or Intranasal Corticosteroids. Ophthalmology 1997; 104: 1653-60.

Kleinberg Aj, Patel C, Lierberman Rm, Malnik Bd. Bilateral Central Serous Chorioretinopathy Caused by Intranasal Corticosteroids: A Case Report and Review of the Literature. Laryngoscope 2011; 121: 2034-7.

Corbé C, Lebail B. Appareil Visuel Et Aviation. Encycl Méd Chir (elsevier, Paris), Ophtalmologie, 21-810-a-05, 1996, 8p.